Armata extends debt maturity to Jan 2026, terminates CMO, hires senior finance and regulatory leaders

Armata Pharmaceuticals, Inc.

Amended credit agreements with Innoviva; maturity moved to January 10, 2026.
Terminated Chief Medical Officer Mina Pastagia, M.D., effective Nov 13, 2024; eligible for 12 months base salary severance.
Hired David House as SVP Finance and Principal Financial Officer; hired Arwa Shurrab to lead regulatory strategy and operations.
Preparing for two potential Phase 3 licensure-supporting trials in 2025 with expanded clinical and regulatory team.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mina Pastagia

Chief Medical Officer

ARMP · Armata Pharmaceuticals, Inc.

Effective: 2024-11-13
Filed: November 15, 2024, 6:59 PM ET

On November 13, 2024 (the “Termination Date”), the Company terminated the employment of Mina Pastagia, M.D. (“Dr. Pastagia”), Chief Medical Officer of the Company, effective as of the close of business on the Termination Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mina Pastagia was terminated as Chief Medical Officer at Armata Pharmaceuticals, Inc..

Action: terminated
Role: Chief Medical Officer

Exact text from the filing

On November 13, 2024 (the “Termination Date”), the Company terminated the employment of Mina Pastagia, M.D. (“Dr. Pastagia”), Chief Medical Officer of the Company, effective as of the close of business on the Termination Date.

View on SEC.gov

Armata Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-119701

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.